Pfizer Inc.: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-07-05
Other years: 2026 vs 2025
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

0
New Risks
3
Removed
17
Modified
6
Unchanged
🔴 No Match in Current Filing GOVERNMENT REGULATION AND PRICE CONSTRAINTS 🔒
🔴 No Match in Current Filing ENVIRONMENTAL MATTERS 🔒
🟡 Modified BUSINESS DEVELOPMENT ACTIVITIES AND STRATEGIC GOALS 🔒
🟡 Modified CHANGES IN LAWS AND ACCOUNTING STANDARDS 🔒
🔴 No Match in Current Filing RAW MATERIALS 🔒
🟡 Modified PRICING AND REIMBURSEMENT 🔒
🟡 Modified RESEARCH AND DEVELOPMENT 🔒
🟡 Modified RESPONSIBLE BUSINESS GROWTH 🔒
🟡 Modified PRODUCT MANUFACTURING, SALES AND MARKETING RISKS 🔒
🟡 Modified LEGAL MATTERS 🔒
🟡 Modified THIRD-PARTY INTELLECTUAL PROPERTY CLAIMS 🔒
🟡 Modified MANAGED CARE TRENDS 🔒
🟡 Modified COLLABORATIONS AND OTHER RELATIONSHIPS WITH THIRD PARTIES 🔒
🟡 Modified COMPETITIVE PRODUCTS 🔒
🟡 Modified DEVELOPMENT, REGULATORY APPROVAL AND MARKETING OF PRODUCTS 🔒
🟡 Modified CONCENTRATION 🔒
🟡 Modified POST-AUTHORIZATION/APPROVAL DATA 🔒
🟡 Modified COST AND EXPENSE CONTROL AND UNUSUAL EVENTS 🔒
🟡 Modified COUNTERFEIT PRODUCTS 🔒
🟡 Modified MARKET FLUCTUATIONS IN OUR EQUITY AND OTHER INVESTMENTS 🔒
20 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →